Ignite Creation Date:
2025-12-24 @ 3:06 PM
Ignite Modification Date:
2026-01-06 @ 6:40 PM
Study NCT ID:
NCT00346359
Status:
COMPLETED
Last Update Posted:
2010-05-14
First Post:
2006-06-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2007-11
Completion Date Type:
ACTUAL
First Submit Date:
2006-06-28
First Submit QC Date:
None
Study First Post Date:
2006-06-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-05-12
Last Update Post Date:
2010-05-14
Last Update Post Date Type:
ESTIMATED